GetTopicDetailResponse(id=2573e388589, topicName=磺脲類藥物, introduction=磺脲類藥物, content=null, image=null, comments=2, allHits=2522, url=https://h5.medsci.cn/topic?id=73885, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=2548, tagList=[TagDto(tagId=2548, tagName=磺脲類藥物)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2223033, encodeId=d3a7222303337, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲雙胍#</a> <a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a> <a href='/topic/show?id=2573e388589' target=_blank style='color:#2F92EE;'>#磺脲類藥物#</a> <a href='/topic/show?id=fcf311e4286f' target=_blank style='color:#2F92EE;'>#ESC 2024#</a>, objectTitle=ESC 2024 | 中國(guó)之聲：在2型糖尿病患者中，二甲雙胍較磺脲類藥物更具抗癌優(yōu)勢(shì), objectType=article, longId=841097, objectId=75c384109eda, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240829/1724911649648_8624274.png, objectUrl=/article/show_article.do?id=75c384109eda, replyNumber=0, likeNumber=131, createdTime=2024-08-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=75c384109eda, moduleTitle=ESC 2024 | 中國(guó)之聲：在2型糖尿病患者中，二甲雙胍較磺脲類藥物更具抗癌優(yōu)勢(shì), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=75c384109eda)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2090266, encodeId=36642090266fe, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲雙胍#</a>通常是T2D的一線治療，并在許多臨床試驗(yàn)中形成基礎(chǔ)治療，這些臨床試驗(yàn)評(píng)估了新的GLD。替代GLD包括鈉-葡萄糖共轉(zhuǎn)運(yùn)體2抑制劑(<a href='/topic/show?id=5c331622ee1' target=_blank style='color:#2F92EE;'>#SGLT2i#</a>)、胰高血糖素樣肽-1受體激動(dòng)劑(GLP-1RA)、二肽基肽酶4抑制劑(<a href='/topic/show?id=03d2622088' target=_blank style='color:#2F92EE;'>#DPP4i#</a>)、<a href='/topic/show?id=2573e388589' target=_blank style='color:#2F92EE;'>#磺脲類藥物#</a>。<a href='/topic/show?id=f8dd10420ed3' target=_blank style='color:#2F92EE;'>#格列齊特#</a>、<a href='/topic/show?id=abae62296da' target=_blank style='color:#2F92EE;'>#格列美脲#</a>、<a href='/topic/show?id=d7dd62295e4' target=_blank style='color:#2F92EE;'>#格列本脲#</a>這些老藥也并不差。<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>, objectTitle=DOM：使用亞洲聯(lián)合糖尿病評(píng)估(JADE)登記系統(tǒng)研究磺脲類藥物在亞洲二型糖尿病患者中的實(shí)際應(yīng)用, objectType=article, longId=740818, objectId=41cee4081830, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/2zKK-712x400.jpg, objectUrl=/article/show_article.do?id=41cee4081830, replyNumber=0, likeNumber=224, createdTime=2022-09-25, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41cee4081830, moduleTitle=DOM：使用亞洲聯(lián)合糖尿病評(píng)估(JADE)登記系統(tǒng)研究磺脲類藥物在亞洲二型糖尿病患者中的實(shí)際應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=41cee4081830)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1241081, encodeId=761712410810d, content=這個(gè)相當(dāng)有意思，在<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>中，大家知道，<a href='/topic/show?id=2573e388589' target=_blank style='color:#2F92EE;'>#磺脲類藥物#</a>降糖是很強(qiáng)的，只是大家會(huì)顧慮其<a href='/topic/show?id=47c7263550d' target=_blank style='color:#2F92EE;'>#低血糖#</a>的安全性問題，但是，這里聯(lián)合<a href='/topic/show?id=a1be1622242' target=_blank style='color:#2F92EE;'>#SGLT-2抑制劑#</a>，如<a href='/topic/show?id=1a17528644d' target=_blank style='color:#2F92EE;'>#恩格列凈#</a><a href='/topic/show?id=d90393941be' target=_blank style='color:#2F92EE;'>#達(dá)格列凈#</a>，這樣既保證能深度降糖，同時(shí)還具有較好的安全性，這確實(shí)是一種選擇！, objectTitle=磺脲類藥物治療2型糖尿病時(shí)若需添加SGLT-2抑制劑，可適當(dāng)減少劑量以降低“低血糖”風(fēng)險(xiǎn), objectType=article, longId=737027, objectId=7b6ee370276e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220825/1661440324017_5121051.jpg, objectUrl=/article/show_article.do?id=7b6ee370276e, replyNumber=0, likeNumber=228, createdTime=2022-08-26, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6ee370276e, moduleTitle=磺脲類藥物治療2型糖尿病時(shí)若需添加SGLT-2抑制劑，可適當(dāng)減少劑量以降低“低血糖”風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7b6ee370276e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
